Lexaria Bioscience Announces Warrant Issuance
Lexaria Bioscience Corp. (CSE:LXX, OTC:LXRP)(the “Company”), a global innovator in drug delivery platforms, announces that on March 16, 2020 it issued share purchase warrants (“Warrants”) to one of its Canadian-based consultants, entitling the consultant to purchase up to 500,000 common shares (“Sha...
17 Mar 2020 ... (CSE:LXX, OTC:LXRP)(the “Company”), a global innovator in drug delivery ... and on Facebook https://www.facebook.com/lexariabioscience/.